Aveanna Healthcare Holdings Inc. (AVAH)
AVAH Chart as of 2025-03-13
Stock Information
| CEO: | – |
| CFO: | – |
| Employees: | 33,500 |
| Address: | 400 Interstate North Parkway SE, Atlanta, GA, United States |
| Country: | United States |
| Website: | https://www.aveanna.com |
| Listing Date: | – |
| Founded: | – |
| Founder: | – |
| Current Price: | 5.139999866485596 USD |
| Today Change: | -3.93% |
| Outstanding Shares: | 193,224,992 |
| Volume: | 3,383,557 |
| Avg Volume: | 251,740 |
| Expert Target Price: | 5.2786 (Institutions: 0) |
| EPS: | – |
| PER: | – |
| Dividend Date: | – |
| Last Split Date: | – |
| Last Split Factor: | – |
Key Executives
| Name | Title | Pay | Year |
|---|---|---|---|
| Mr. Rodney D. Windley | Executive Chairman | 120.5k | — |
| Mr. Jeffrey S. Shaner | CEO & Director | 1.1M | — |
| Mr. Ed Reisz | Chief Administrative Officer | 649.39k | — |
| Mr. Matthew Buckhalter | CFO & Principal Financial Officer | — | — |
| Ms. Deborah Stewart | Senior VP & Principal Accounting Officer | — | — |
| Mr. Patrick A. Cunningham | Chief Compliance Officer | — | — |
| Mr. Jerry Perchik | Chief Legal Officer & Secretary | — | — |
| Ms. Kristy Rohwedder | President of Private Duty Nursing | — | — |
| Mr. Shane Brinkerhoff | President of Home Health & Hospice | — | — |
| Ms. Rachel Witt | Chief Clinical Officer | — | — |
Financials
Income Statement
| Metric | Amount |
|---|---|
| Total Revenue | 1,895,209,000 |
| Cost Of Revenue | 1,299,777,000 |
| Gross Profit | 595,432,000 |
| Operating Income | 113,674,000 |
| Net Income | -134,524,000 |
Balance Sheet
| Metric | Amount |
|---|---|
| Total Assets | 1,612,985,000 |
| Total Liabilities | – |
| Total Stockholder Equity | – |
Cash Flow
| Metric | Amount |
|---|---|
| Total Cash From Operating Activities | – |
| Capital Expenditures | – |
SEC Filings (Gemini Summaries)
| AccNo | Date | Summary |
|---|---|---|
| 0001193125-25-053958 | 2025-03-13 | Aveanna Healthcare files Form S-8 to register 3,864,503 additional shares of common stock for its 2021 Stock Incentive Plan, effective Jan 1, 2025, per the plan’s evergreen provision. |
| 0001193125-25-053955 | 2025-03-13 | Aveanna Healthcare files Form S-8 to register shares for its 2021 Employee Stock Purchase Plan. It registers 1,801,642 additional shares available due to an annual increase provision. Prior filings are incorporated by reference. |
| 0000950170-25-038504 | 2025-03-13 | The 10-K filing (0001832332) references various financial items: revenue, loans, interest rates (SOFR), stock plans, assets, and agreements. Key dates include 2023-01-01 to 2023-12-30 and 2024-12-28. Mentions customer concentration risk and home care equipment. |
| 0000950170-25-038316 | 2025-03-13 | Aveanna Healthcare (AVAH) filed an 8-K on March 13, 2025, reporting financial results for the period ending Dec 28, 2024 (Item 2.02). Exhibit 99.1 is the press release detailing these results. |
| 0000950170-25-032992 | 2025-03-04 | SEC Form 4 filing. Reports changes in beneficial ownership for Aveanna Healthcare Holdings, Inc. (AVAH). Director Windley Rodney D. reported a transaction on 02/28/2025. Filed individually. |
News Summary
– Aveanna Healthcare (AVAH) Projected to Post Earnings on Thursday
2025-03-11 06:18:46 | ETF Daily News
Aveanna Healthcare (NASDAQ:AVAH) is expected to release its earnings data before the market opens on Thursday, March 13th. Analysts expect Aveanna Healthcare to post earnings of $0.00 per share and revenue of $499.61 million for the quarter.
Link
Analysis of Today’s Move
**Aveanna Healthcare Stock Decline: A Multi-Faceted Analysis**
Aveanna Healthcare’s (AVAH) stock likely declined today due to a combination of factors revealed in recent filings. The expected earnings announcement on Thursday, March 13th, created initial market anticipation. However, the simultaneous release of SEC filings likely tempered investor enthusiasm. These filings suggest potential dilution and underlying financial concerns.
The filing of two Form S-8 registrations signals a potential increase in the outstanding share count. Registering 3,864,503 shares for the 2021 Stock Incentive Plan increases potential dilution. The registration of 1,801,642 shares for the Employee Stock Purchase Plan adds to this effect. This dilution could decrease the value of existing shares, impacting stock price.
The 8-K filing regarding financial results ending Dec 28, 2024, is particularly important. The press release (Exhibit 99.1) detailing the results likely contained disappointing information. Investors often react negatively to earnings misses or lowered guidance. Further examination of the 8-K’s specifics is needed to confirm this.
The 10-K filing incorporates references to various financial items and risks. It mentions revenue, loans, interest rates (SOFR), and customer concentration risk. The report also notes home care equipment, potentially indicating capital expenditure challenges. These details could have painted a concerning picture for investors.
Director Windley Rodney D.’s recent transaction reported in the Form 4 filing should also be considered. While individual transactions are not always indicative, they can influence investor sentiment. A significant sale by a director might signal a lack of confidence. Therefore, the stock’s decline appears to be a result of multiple concerns.
This stock has shown a change of -3.93% today.
Please consider that all investment decisions carry risk;
none of the content here should be construed as financial advice.
Always do your own research or consult a professional before making investment decisions.
The information provided in this article is for informational purposes only
and does not constitute legal, tax, or investment advice.
Investing involves risk, including the potential loss of principal.
Leave a Reply